[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100650478":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":20,"locations":29,"responsibleParty":86,"collaborators":10,"id":88,"slug":89,"hasResults":90,"nctId":91,"briefTitle":92,"officialTitle":92,"acronym":93,"eligibilityCriteria":94,"healthyVolunteers":90,"sex":95,"minAge":10,"maxAge":10,"enrollmentInfo":96,"targetDuration":99,"studyType":100,"phases":10,"briefSummary":101,"conditions":102,"keywords":107,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":114,"completionDateStruct":116,"leadSponsor":118,"locationsCount":119},{"fullName":5,"class":6},"Target PharmaSolutions, Inc.","INDUSTRY",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Disease Cohort",null,"Adult patients and patients under the age of majority with a diagnosis of DD by ICD or other relevant healthcare code in the EHR interface.",{"label":13,"type":10,"description":14,"interventionNames":10},"Engaged Cohort","Adult patients and patients under the age of majority diagnosed and managed for DD invited to participate OR HCPs who treat patients with these conditions.\n\n* Informed consent is required for all participants in an Engaged Cohort.\n* Willing to complete required Engaged Cohort activities.",[16],{"name":17,"affiliation":18,"role":19},"Laura Dalfonso","Pedestal Health","STUDY_DIRECTOR",[21,26],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Lynda Lee Burch","CONTACT","9842340268","lburch@pedestalhealth.com",{"name":27,"role":23,"phone":24,"phoneExt":10,"email":28},"Danisha Devane","ddevane@pedestalhealth.com",[30,52,65],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Wake Forest University Health Science","RECRUITING","Winston-Salem","North Carolina","27157","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-80.24422,36.09986,{"lat":42,"lon":41},[45,49],{"name":46,"role":23,"phone":47,"phoneExt":10,"email":48},"Irma Richardson","336-716-7740","Irma.Richardson@advocatehealth.org",{"name":50,"role":51,"phone":10,"phoneExt":10,"email":10},"Steven Feldman, MD","PRINCIPAL_INVESTIGATOR",{"facility":53,"status":32,"city":54,"state":55,"zip":56,"country":36,"countryCode":37,"cosmosGeoPoint":57,"geoPoint":61,"contacts":62},"University of Pennsylvania","Philadelphia","Pennsylvania","19104",{"type":39,"coordinates":58},[59,60],-75.16362,39.95238,{"lat":60,"lon":59},[63],{"name":64,"role":51,"phone":10,"phoneExt":10,"email":10},"Joel Gelfand, MD",{"facility":66,"status":32,"city":67,"state":68,"zip":69,"country":36,"countryCode":37,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"Medical University of South Carolina","Charleston","South Carolina","29407",{"type":39,"coordinates":71},[72,73],-79.93275,32.77632,{"lat":73,"lon":72},[76,80,84],{"name":77,"role":23,"phone":78,"phoneExt":10,"email":79},"Patrick Cote","843-792-3746","cotp@musc.edu",{"name":81,"role":23,"phone":82,"phoneExt":10,"email":83},"Courtney Rowley","843-792-9784","rowle@musc.edu",{"name":85,"role":51,"phone":10,"phoneExt":10,"email":10},"Lara Wine-Lee, MD",{"type":87,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100650478","an-observational-study-of-patients-with-dermatologic-disease-100650478",false,"NCT07748169","An Observational Study of Patients With Dermatologic Disease","TARGET-DERM+","Inclusion Criteria:\n\n* Adult or pediatric participants managed for DD invited to participate OR a provider who treats patients with these conditions. Informed consent is required for all Engaged Cohort participants.\n* Adult or pediatric participants at the time of enrollment with a diagnosis of DD by ICD code or other relevant healthcare code as part of the EHR interface.\n\nExclusion Criteria:\n\n* Participant withdrew consent; Failure to complete activities as required per the cohort clarification letter.","ALL",{"count":97,"type":98},2000000,"ESTIMATED","15 Years","OBSERVATIONAL","TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who treat these patients. The study includes patients managed for DD of any etiology in usual clinical practice in the United States and addresses important clinical questions regarding the management of DD by collecting and analyzing data from patients at academic medical centers and community medical practices and\u002For data from providers who treat them.",[103,104,105,106],"Vitiligo","Atopic Dermatitis","Alopecia Areata","Hidradenitis Suppurativa (HS)",[108,109],"Dermatologic Disease","DERM+","2026-07-31",{"date":112,"type":113},"2026-08-05","ACTUAL",{"date":115,"type":98},"2026-08-01",{"date":117,"type":98},"2041-08-03",{"name":5,"class":6},3]